Classification of high-risk depressed mood groups in cancer patients based on Health Ecology Model
Youhua Lu,Yuantao Qi,Jin Du,Yan Liu,Shihong Dong,Huaiju Ge,Yuan Yu,Jialin Wang,Nan Zhang,Bingxiang Wang,Guifeng Ma
DOI: https://doi.org/10.1016/j.jad.2023.11.061
IF: 6.533
2023-11-22
Journal of Affective Disorders
Abstract:Background Depressed mood affects a significant number of patients with cancer, and can impair their quality of life and interfere with successful treatment. Our study aims to create a predictive model for identifying high-risk groups of depressed mood in cancer patients, offering a theoretical support for preventing depressed mood in these individuals. Methods The China Health and Retirement Longitudinal Study (CHARLS) provided the data for this research, which used CES-D as a tool to identify individuals with depressed mood. Influencing factors of depressed mood in cancer patients was analyzed using a binary logistic regression model. Using the Harvard Cancer Index, we classified the high-risk patients for depressed mood. Results In present study, 52.96 % of cancer patients met criteria for depressed mood based on the CES-D. Significant correlations were found between depressed mood and factors such as gender, self-rated health, sleep duration, exercise, satisfaction with family, residence, education, life satisfaction, and medical insurance. Utilizing the Harvard Cancer Index, we classified patients into five risk levels for depressed mood, revealing a significant variation in the number of depressive patients across these levels ( x2 =99.82, P < 0.05). Notably, the incidence of depressed mood increased with the risk level among cancer patients ( x2 =103.40, P < 0.05). Limitations Lack of data on tumor typing and subgroups makes it unlikely to explore the specifics of depressed mood in patients with various types of cancer. Conclusion The determinants of depressed mood in cancer patients are multi-dimensional. The Harvard Cancer Index may be helpful in identifying high-risk populations.
psychiatry,clinical neurology